Trademark Search  /  CYTEGRITY

CYTEGRITY

○ Dead · Abandoned

U.S. federal trademark · Serial No. 88583412

Mark
CYTEGRITY
Status
Abandoned
Serial Number
88583412
Filing Date
August 19, 2019
Class(es)
Class 001, Class 005

Owners

CSL BEHRING GENE THERAPY, INC.
03 · TUSCON, AZ, US
Calimmune, Inc.
03 · Tucson, AZ, US
Calimmune, Inc.
03 · Tucson, AZ, US

Goods & Services

Cell lines for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research

Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "CYTEGRITY" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.